Alivus Life Sciences Ltd

NSE: ALIVUS · BSE: 543322 · Pharmaceuticals & Biotechnology · 34 announcements

Share price: ₹1,454.90
Market cap: ₹17,891 Cr
Revenue (annual): ₹2,552 Cr
Net profit (annual): ₹564.5 Cr
P/E (TTM): 26.7×Sector 43.8×
Promoter holding: 74.85%-0.02% QoQ
FII holding: 5.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Results Update 1 Promoter Selling 1 Other Announcement 1 Financial Results 1 Employee Stock Options 1 Board Meeting Date 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

11 Nov 2026 16:52 IST BSE

Acquisition

Alivus Life Sciences Acquisition

Alivus Life Sciences signed a Shareholders' Agreement with IQGEN-X Pharma and its continuing shareholders. It governs inter se rights after the company's 76% IQGEN-X stake purchase.

Open announcement → Read the filing ↗